SCI & TECH● LOWAug 19 · Aug 19, 2026, 8:59 AM
Novo Nordisk tests low-dose Wegovy pill in new study
Seeking Alpha Tech
Novo Nordisk is conducting a new study to test a low-dose pill version of its drug, Wegovy. This research could impact future treatment options.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH1h agoHave scientists discovered a dark matter particle?Al Jazeera [en]SCI & TECH1h agoNew reality for China’s entertainment sector as AI drama goes prime timeSouth China Morning PostSCI & TECH1h agoMedieval manuscripts made from animal skin reveal ancient history of deadly sheep virusEuroNews [en]SCI & TECH2h agoAsia - Pacific SMEs seek new growth through AI , deeper connectivityaustraliannews.net · Australia